AMANDA DOBIL: Open Payments
NPI 1952859316 · GREENWOOD VILLAGE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,331 in 93 payments from 16 companies in 2025. Trend: 2023 $2,339 · 2024 $1,594 · 2025 $2,331
Food & beverage: $2,331
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $727 |
| GlaxoSmithKline, LLC. | 15 | $322 |
| Regeneron Healthcare Solutions, Inc. | 17 | $214 |
| Electromed, Inc. | 13 | $195 |
| GENZYME CORPORATION | 11 | $166 |
| Merck Sharp & Dohme LLC | 3 | $159 |
| United Therapeutics Corporation | 2 | $148 |
| Ethicon Inc. | 1 | $146 |
| SCPHARMACEUTICALS INC. | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, FASENRA, SMARTVEST, WINREVAIR, Monarch Platform, BREZTRI.
Industry payments across CO — which companies pay providers there.
